Bispecific antibodies and CAR-T cells have transformed the myeloma treatment landscape in recent years, providing hope for patients with relapsed/refractory (R/R) disease. While both of these therapies offer benefits to patients, there are challenges to address regarding the optimal sequencing of these agents.
In this podcast, experts Salomon Manier, MD, PhD, Lille University Hospital, Lille, France, Surbhi Sidana, MD, Stanford University, Stanford, CA, and Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany, share some interesting insights into the optimal sequencing of bispecific antibodies and CAR-T cells in myeloma, highlighting data from recent clinical trials.
The AML Sessions: IDH inhibitors
The AML sessions: advances in immuno-oncology from SOHO 2020
Advances in CAR-T and cellular therapy from EBMT 2020: MSCs, clinical trial updates and gene-edited effector cells
SOHO 2020: Next questions in hematological malignancies
CLL therapy: the latest trial updates and innovative novel therapies for the future
The MPN Sessions: pathobiology, therapeutic strategies & clinical trials
Latest AML therapies: novel preparations and first in class agents
Advances in the lymphoma space: targeted therapies, PET-guided omission of RT and CAR T-cells
The Myeloma Sessions: Evolving management of myeloma & COVID-19
CLL: MRD and first-in-class agents
MPNs highlights at EHA 2020: clinical trials, novel therapies & pitfalls
The CLL Sessions: frontline therapy, BTK inhibitors, MRD negativity & novel therapies
The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resourc...
The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML
Key updates in ALL at EHA 2020
The Myeloma Sessions: smoldering myeloma, MRD evaluation, R/R disease & transplant-eligible patients
Systemic mastocytosis: current landscape, novel agents and COVID-19
MRD assessment in AML: incorporation into clinical practice
Myeloma management in the COVID-19 era
CAR-T in the CLL space
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.